In this Accuray blog, insights from an international, multidisciplinary course hosted by Unicancer at the Geneva Innovation Hub explore what it truly takes to integrate AI safely, effectively, and ethically into clinical workflows.
Bringing together perspectives from radiation oncologists, medical physicists, legal experts, and ethicists, the article moves beyond theory to examine real-world clinical use cases. It highlights how supervised automation can improve efficiency—such as in thoracic radiotherapy contouring—while also revealing where variability, validation gaps, and over reliance on AI can introduce risk. As one key message reinforces: quality in, quality out—AI systems can only be as reliable as the data, definitions, and clinical oversight that shape them.
The blog also addresses emerging regulatory realities, including the implications of the EU AI Act, cross border liability, and the growing expectation for transparent documentation and human oversight. Ethical considerations are treated not as an abstract concept, but as an operational responsibility—challenging clinicians and institutions to remain active stewards of AI rather than passive users.
For clinicians navigating the expanding role of AI in radiosurgery and precision radiotherapy, this article offers timely reflections on readiness, governance, and patient safety—underscoring that responsible deployment is ultimately about infrastructure, culture, and clinical accountability.
Read the full blog to explore what responsible AI deployment in radiation oncology really takes.